Harbourvest Partners LLC Veracyte, Inc. Transaction History

Harbourvest Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $766,471 - $1.46 Million	-23,591 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $630,587 - $841,490	23,591 New	23,591 $766,000
Q4 2019 Feb 13, 2020	SELL	$20.78 - $29.99 $1.76 Million - $2.55 Million	-84,875 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $2.03 Million - $2.63 Million	84,875 New	84,875 $2.04 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Harbourvest Partners LLC with notifications on news.